JD HEALTH-R News

JD HEALTH(6618.HK):MIXED 1H24;COMMITTED STRATEGIES AMID POST-COVID ERA

中银国际25minutes ago

JD Health (6618.HK): Profit side exceeds expectations and has sufficient cash reserves

Aug 18 00:00

Morgan Stanley Downgrades JD Health International to Underweight From Equal-weight; Price Target Is HK$20.40

MT NewswiresJul 17 13:22

JD Health (06618.HK): The impact of the high base figure is nearing its end, pay attention to signs of fundamental recovery throughout the year

May 18 00:00

JD Health (06618.HK): Three-party merchant ecosystem construction accelerates full coverage of online and offline medical scenarios

天風證券Apr 2 11:11

JD Health (6618.HK): Gross margin is expected to continue to recover, and service revenue is expected to maintain rapid growth

Mar 28 00:00

JD Health (06618.HK) 2023 Annual Report Performance Review: Reducing Costs and Increasing Efficiency to Develop New Quality Productivity Layout Medical Services

Mar 27 00:00

JD Health (6618.HK): Expanding the Tripartite Merchant Ecosystem to Help Return to an Endogenous Growth Path

Mar 24 00:00

JD Health (6618.HK) 2023 Report Review: The number of merchants on the three sides increased dramatically, and the big model helped reduce costs and increase efficiency

Mar 24 00:00

JD Health (6618.HK): Performance growth exceeds expectations, omnichannel business layout accelerates

Mar 23 00:00

Nomura Adjusts JD Health's Price Target to HK$44 to HK$37, Keeps at Buy

MT NewswiresMar 22 17:01

JD Health (06618.HK): Focus on the impact of a high base on growth performance in 2024 after clearing

Feb 22 11:21

Changes in Hong Kong stocks | JD Health (06618) rose more than 7% in the intraday period, institutions are optimistic about the company's revenue prospects, rising earnings estimates and target prices

Zhitong FinanceJan 23 11:11

Bank of America Ratings | Bank of America: Reiterates JD Health's “Buy” Rating Upgrades Last Year's Revenue Forecast

Gelonghui FinanceJan 22 13:58

Nomura Adjusts JD Health International's Price Target to HK$44 From HK$60, Keeps at Buy

MT NewswiresJan 19 18:15

Changes in Hong Kong stocks | JD Health (06618) rose more than 3%, the health supplement category grew strongly, and institutions raised revenue forecasts and target prices

Zhitong FinanceJan 19 11:23

JD Health (6618.HK): Expecting the return of endogenous growth after the high base effect

華泰證券Nov 28, 2023 20:16

JD Health (06618.HK): The number of users continued to grow in 23Q3, focusing on the promotion of omni-channel business layout

廣發證券Nov 27, 2023 00:00

JD Health (6618.HK): Active users of the platform continue to grow, and the integrated online and offline layout is progressing steadily

Nov 23, 2023 19:16

Bank Ratings｜Daimo: First to JD Health's “Sync with the Market” rating target price of HK$43

Gelonghui FinanceNov 23, 2023 09:46